èšåºæ®µéã®ãã€ãªå»è¬åäŒæ¥ã§ãã NuCana plc ã¯ãããæ²»ççšã®è£œåã®éçºã«æºãã£ãŠããŸããå瀟ã¯ãç¬èªã® ProTide æè¡ã«åºã¥ããŠè£œåãéçºããŠããŸããäž»ãªè£œååè£ã«ã¯ãé²è¡æ§åºåœ¢è
«çæ£è
ã察象ãšãã第 I çžèšåºè©Šéšãåçºæ§åµå·£ããæ£è
ã察象ãšãã第 Ib çžèšåºè©Šéšãèéããæ£è
æ²»çã®ç¬¬ III çžèšåºè©Šéšããã©ããèæ§åµå·£ããæ£è
æ²»çã®ç¬¬ II çžèšåºè©Šéšã転移æ§èµèããæ£è
æ²»çã®ç¬¬ III çžèšåºè©Šéšãè¡ãããŠãã Acelarin ããããŸããå瀟ã¯ãŸããé²è¡æ§åºåœ¢è
«çæ£è
æ²»çã®ç¬¬ I çžèšåºè©Šéšãè¡ãããŠãã 5-ãã«ãªããŠã©ã·ã«ã®æŽ»æ§æãã代è¬ç©ã® ProTide 倿ã§ãã NUC-3373ãããã³é²è¡æ§åºåœ¢è
«çããã³è¡æ¶²è
«çæ£è
æ²»çã®ç¬¬ I çžèšåºè©Šéšãè¡ãããŠãããã¯ã¬ãªã·ãé¡äŒŒäœ NUC-7738 ãéçºããŠããŸãã NuCana plc ã¯ãProTides ã®èšèšãåæãç¹æ§è©äŸ¡ãè©äŸ¡ã«é¢ããŠã«ãŒãã£ã倧åŠããã³ãŠãããŒã·ã㣠ã«ã¬ããž ã«ãŒãã£ã ã³ã³ãµã«ã¿ã³ã瀟ãšç ç©¶ãååãã©ã€ã»ã³ã¹å¥çŽãçµãã§ããããŸãã«ãŒãã£ã ProTides 瀟ãšã¯è²æž¡ãã©ã€ã»ã³ã¹ãååå¥çŽãçµãã§ããŸããå瀟ã¯ä»¥å㯠NuCana BioMed Limited ãšããŠç¥ãããŠããŸãããã2017 幎 8 æã« NuCana plc ã«ç€Ÿåã倿ŽããŸãããNuCana plc 㯠1997 幎ã«èšç«ãããæ¬ç€Ÿã¯ã€ã®ãªã¹ã®ãšãã£ã³ãã©ã«ãããŸãã